David R. Hathaway, Chief Medical Officer at HeartWare International, Inc. (HTWR), sold 4,254 shares at $91.69 ($393K) on 2012-09-17, disclosed to the SEC on 2012-09-18.
Scheduled sale ($393k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.69 | 459 | $42K | 10.7% |
| 2 | $92.49 | 2,879 | $266K | 67.7% |
| 3 | $91.94 | 406 | $37K | 9.5% |
| 4 | $92.84 | 510 | $47K | 12.0% |
| Total | $92.39 avg | 4,254 | $393K | 100% |
| Filing → |
| HTWR | SELL | 2013-05-30 | $564K | — | Filing → |
| HTWR | SELL | 2013-05-22 | $2.8M | — | Filing → |
| HTWR | SELL | 2012-12-26 | $88K | — | Filing → |